Yifeng Pharmacy Chain Co Ltd
SSE:603939
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
CN |
|
WP Carey Inc
NYSE:WPC
|
US |
|
Loop Industries Inc
NASDAQ:LOOP
|
CA |
|
I
|
Ithaca Energy PLC
LSE:ITH
|
UK |
|
Bukalapak.com Tbk PT
IDX:BUKA
|
ID |
|
LendingClub Corp
NYSE:LC
|
US |
|
Akzo Nobel NV
AEX:AKZA
|
NL |
|
Panasonic Holdings Corp
TSE:6752
|
JP |
|
Davide Campari Milano NV
MIL:CPR
|
IT |
Wall St Price Targets
Price Targets Summary
Yifeng Pharmacy Chain Co Ltd
According to Wall Street analysts, the average 1-year price target for Yifeng Pharmacy Chain Co Ltd is 34.74 CNY with a low forecast of 24.24 CNY and a high forecast of 45.44 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Yifeng Pharmacy Chain Co Ltd's stock price target?
Price Target
34.74
CNY
According to Wall Street analysts, the average 1-year price target for Yifeng Pharmacy Chain Co Ltd is 34.74 CNY with a low forecast of 24.24 CNY and a high forecast of 45.44 CNY.
What is the Revenue forecast for Yifeng Pharmacy Chain Co Ltd?
Projected CAGR
10%
Over the last 12 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Yifeng Pharmacy Chain Co Ltd?
Projected CAGR
18%
Over the last 12 years, the compound annual growth rate for Operating Income has been 28%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for Yifeng Pharmacy Chain Co Ltd?
Projected CAGR
15%
Over the last 12 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 15%.
